Prescribing in care homes: The role of the geriatrician

Therapeutic Advances in Chronic Disease

Volumn 2, Issue 6, 2011, Pages 353-358

  Burns, Eileen ^a   Mcquillan, Nuala ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Aged; Drug toxicity; Geriatric assessment; Nursing homes; Physician prescribing patterns; Polypharmacy

Indexed keywords

ARTICLE; DRUG SAFETY; DRUG USE; ELDERLY CARE; GENERAL PRACTITIONER; GERIATRIC ASSESSMENT; GERIATRIC CARE; GOOD CLINICAL PRACTICE; HOME CARE; HUMAN; MEDICAL SERVICE; NURSING HOME; PATIENT ATTITUDE; PATIENT SAFETY; PHARMACIST ATTITUDE; PHYSICIAN ATTITUDE; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS;

EID: 84859087823     PISSN: 20406223     EISSN: 20406231     Source Type: Journal    
DOI: 10.1177/2040622311421438     Document Type: Article

References (62)

1. Alexopoulos G.S. Streim J. Carpenter D. Docherty J.P. (2004) Expert consensus panel for using antipsychotic agents in older patients. J Clin Psychiatry 65(Suppl. 2): 5–9.
2. Alexopoulou A. Dourakis S.P. Mantzoukis D. Pitsariotis T. Kandyli A. Deutsch M. et al. (2008) Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Intern Med 19: 505–510, [Epub 11 March 2008].
3. Bebbington A. Darton R. Netton A. (2001) Care Homes for Older People. Vol. 2: Admission, Needs and Outcomes The 1995 / 96 National Longitudinal Survey of Publicly-funded Admissions, Personal Social Services Research Unit, University of Kent: Canterbury.
4. Beers M.H. Ouslander J.G. Rollingher I. Reuben D. Brooks J. (1991) Explicit criteria for determining inappropriate medication use in nursing homes. Arch Intern Med 151: 1825–1832.
5. Comas-Herrera A. Wittenberg R. Pickard L. (2001) Projections of demand for residential care for older people in England to 2020, Personal Social Services Research Unit, University of Kent: Canterbury.
6. Corsonello A. Pedone C. Incalzi R.A. (2010) Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem 17: 571–584.
7. Crooks J. O'Malley K. Stevenson I.H. (1976) Pharmacokinetics in the elderly. Clin Pharmacokinet 1: 280–296.
8. Crotty M. Halbert J. Rowett D. Giles L. Birks R. Williams H. et al. (2004 a) An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 33: 612–617.
9. Crotty M. Rowett D. Spurling L. Giles L.C. Phillips P.A. (2004 b) Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 4: 257–264.
10. Delafuente J.C. (2008) Pharmacokinetic and pharmacdynamic alterations in the geriatric patient. Consult Pharm 23: 324–334.
11. Fick D. Cooper J. Wade W. Waller J. Maclean J. Beers M. (2003) Updating the Beers Criteria for inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163: 2716–2724.
12. Franceschi M. Scarcelli C. Niro V. Seripa D. Pazienza A.M. Pepe G. et al. (2008) Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 31: 545–556.
13. French D. Campbell R. Spehar A.M. Accomando J. (2007) How well do psychotropic medications match mental health diagnoses? A national view of potential off-label prescribing in VHA nursing homes. Age Ageing 36: 107–108.
14. Furniss L. (2002) The use of medicines in nursing homes for older people. Adv Psychiatric Treatment 8: 198–204.
15. Garcia R.M. (2006) Five ways you can reduce inappropriate prescribing in the elderly: a systematic review. J Fam Pract 55: 305–312.
16. Gill S.S. Bronskill S.E. Normand S.L. Anderson G.M. Sykora K. Lam K. et al. (2007) Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 146: 775–786.
17. Gosney M. Tallis R. (1984) Prescription of contra-indicated and interacting drugs in elderly patients admitted to hospital. The Lancet 324: 564–567.
18. Granek E. Baker S.P. Abbey H. Robinson E. Mayers A.H. Samkoff J.S. et al. (1987) Medications and diagnoses in relation to falls in a long-term care facility. J Am Geriatr Soc 35: 503–511.
19. Gray S. Odegard P.S. Sales A.E. Young H.M. Sullivan J.H. Hedrick S.C. (2006) Quality of medication records and use of pharmacy resources in community residential care facilities. Ann Pharmacother 40: 894–899.
20. Gurwitz J.H. Field T.S. Radford M.J. Harrold L.R. Becker R. Reed G. et al. (2007) The safety of warfarin therapy in the nursing home setting. Am J Med 120: 539–544.
21. Hilmer S.N. McLachlan A.J. Le Couteur D.G. (2007) Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 21: 217–230.
22. Hilmer S.N. Shenfield G.M. LeConteur D.G. (2005) Clinical implications of changes in drug hepatic metabolism in older people. Ther Clin Risk Manag 1: 151–156.
23. Holmquist I.B. Svensson B. Hoglund P. (2003) Psychotrophic drugs in nursing- and old-age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol 59(8–9): 669–676.
24. Howard R.L. Avery A.J. Howard P.D. Partidge M. (2003) Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 12: 280–285.
25. Johnell K. Weitoft G.R. Fastbom J. (2009) Sex differences in inappropriate drug use: a register-based study of over 600,000 older people. Ann Pharmacother 43: 1233–1238.
26. Kaur S. Mitchell G. Vitetta L. Roberts M.S. (2009) Interventions that can reduce inappropriate prescribing in the elderly; a systematic review. Drugs Aging 26: 1013–1028.
27. Khunti K. Kinsella B. (2000) Effect of systematic review of medication by general practitioner among drug consumption in nursing home residents. Age Ageing 29: 451–453.
28. Lapsley R. (1988) Prescription monitoring in a nursing home. Pharm J 240: 688–690.
29. Lau D.T. Kasper J.D. Potter D.E. Lyles A. Bennett R.G. (2005) Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 165: 68–74.
30. Lauritzen J. McNair P. Lund B. (1993) Risk factors for hip fractures. Dan Med Bull 40: 479–485.
31. Le Couteur D.G. McLean A.J. (1998) The aging liver: drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet 34: 359–373.
32. McLean A.J. Le Couteur D.G. (2004) Aging biology and geriatric clinical pharmacology. Pharmacol Rev 56: 163–184.
33. McLeod P. Huang A. Tamblyn R. Gayton D.C. (1997) Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 156: 385–391.
34. McShane R. Keene J. Gedling K. Fairburn C. Jacoby R. Hope T. (1997) Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow-up. BMJ 314: 266–270.
35. Mort J.R. Aparasu R.R. (2000) Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Arch Intern Med 160: 2825–2831.
36. Muhlberg W. Platt D. (1999) Age-dependent changes of the kidneys: pharmacological implications. Gerontology 45: 243–253.
37. Department of Health. (2001) National Services Framework for Older People, London.
38. Nguyen J.K. Fouts M.M. Kotabe S.E. Lo E. (2006) Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 4: 36–41.
39. N.H.S. Information Centre. (2010) Adult Social Care Statistics. Information and Guidance on Adult Social Care Combined Activity Return, NHS Information Centre: Leeds.
40. Nishtala P.S. McLachlan A.J. Bell J.S. Chen T.F. (2009) Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study. Am J Geriatr Pharmacother 4: 210–219.
41. Oliver D. Connelly J.B. Victor C.R. Shaw F.E. Whitehead A. Genc Y. et al. (2007) Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analysis. BMJ 334: 82–85.
42. O'Mahony D. Gallagher P.F. (2008) Inappropriate prescribing in the older population: need for new criteria. Age Ageing 37: 138–141.
43. Parikh S. Avorn J. Solomon D.H. (2009) Pharmacological management of osteoporosis in nursing home populations: a systematic review. J Am Geriatr Soc 57: 327–334.
44. Passalacqua G. (2010) Adverse drug reactions as the cause of emergency department admission: focus on the elderly. Immunopharmacol Immunotoxicol 32: 426–429.
45. Passarelli M.C. Jacob-Filho W. Figueras A. (2005) Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 22: 767–777.
46. Patel H. Bell D. Molokhia M. Srishanmuganathan J. Patel M. Car J. et al. (2007) Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005. BMC Clin Pharmacol 7: 9.
47. Pirmohamed M. James S. Meakin S. Green C. Scott A.K. Walley T.J. et al. (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329: 15–19.
48. Quilliam B.J. Lapane K.L. (2001) Clinical correlates and drug treatment of residents with stroke in long-term care. Stroke 32: 1385–1393.
49. Routledge P. O'Mahoney M.S. Woodhouse K.W. (2004) Adverse drug reactions in the elderly. Br J Clin Pharmacol 57: 121–126.
50. Schmader K.E. Hanlon J.T. Pieper C.F. Sloane R. Ruby C.M. Twersky J. et al. (2004) Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 116: 394–401.
51. Spore D.L. Mor V. Larratt P. Hawes C. Hiris J. (1997) Inappropriate drug prescriptions for elderly residents of board and care facilities. J Public Health 87: 404–409.
52. van der Hooft C.S. Sturkenboom M.C. van Grootheest K. Kingma H.J. Stricker B.H. (2006) Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. Drug Saf 29: 161–168.
53. Veehof L.J. Stewart R.E. Mayboom-de Jong B. Haaijer-Ruskamp F.M. (1999) Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 55: 533–536.
54. Ventura M.T. Laddaga R. Cavallera P. Pugliese P. Tummolo R.A. Buquicchio R. et al. (2010) Adverse drug reactions as a cause of emergency department admission: focus on the elderly. Immunopharmacology and immunotoxicity 32: 426–429.
55. Walley T. Scott A.K. (1995) Prescribing in the elderly. Postgrad Med J 71: 466–471.
56. Wiffen P. Gill M. Edwards J. Moore A. (2002) Adverse drug reactions in hospital patients. Bandolier Extra June: 1–15.
57. Williams A. Manias E. Walker R. (2008) Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs 63: 132–143.
58. Williams B. Betley C. (1995) Inappropriate use of nonpsychotrophic medications in nursing homes. J Am Geriatr Soc 43: 513–519.
59. Wright R. (2007) Use of osteoporosis medications in older nursing facility residents. J Am Med Dir Assoc 8: 453–457.
60. Wu T.Y. Jen M.H. Bottle A. Molokhia M. Aylin P. Bell D. et al. (2010) Ten-year trends in hospital admissions for drug reactions in England 1999-2009. J R Soc Med 103: 239–250.
61. Zermansky A. Alldred D. Petty D. Raynor D. Freemantle N. Eastugh J. et al. (2006) Clinical medication review by a pharmacist of elderly people living in care homes – randomised controlled trial. Age Ageing 35: 586–591.
62. Zhan C. Sangl J. Bierman A.S. Miller M.R. Friedman B. Wickizer S.W. Meyer G.S. (2001) Potentially inappropriate medication use in the community-dwelling elderly findings from the 1996 medical expenditure panel survey. JAMA 286: 2823–2829.